Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:636918.
doi: 10.1155/2015/636918. Epub 2015 Nov 19.

Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection

Franziska M Ippen  1 , Anand Mahadevan  2 , Eric T Wong  3 , Erik J Uhlmann  3 , Soma Sengupta  3 , Ekkehard M Kasper  1
Affiliations

Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection

Franziska M Ippen et al. J Oncol. 2015.

Abstract

Background. Renal cell carcinoma is a frequent source of brain metastasis. We present our consecutive series of patients treated with Stereotactic Radiosurgery (SRS) and analyse prognostic factors and the interplay of WBRT and surgical resection. Methods. This is a retrospective study of 66 patients with 207 lesions treated with the Cyberknife radiosurgery system in our institution. The patients were followed up with imaging and clinical examination 1 month and 2-3 months thereafter for the brain metastasis. Patient, treatment, and outcomes characteristics were analysed. Results. 51 male (77.3%) and 15 female (22.7%) patients, with a mean age of 58.9 years (range of 31-85 years) and a median Karnofsky Performance Status (KPS) of 90 (range of 60-100), were included in the study. The overall survival was 13.9 months, 21.9 months, and 5.9 months for the patients treated with SRS only, additional surgery, and WBRT, respectively. The actuarial 1-year Local Control rates were 84%, 94%, and 88% for SRS only, for surgery and SRS, and for WBRT and additional SRS, respectively. Conclusions. Stereotactic radiosurgery is a safe and effective treatment option in patients with brain metastases from RCC. In case of a limited number of brain metastases, surgery and SRS might be appropriate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival by treatment modality.
Figure 2
Figure 2
Overall survival by number of brain metastases.
Figure 3
Figure 3
Overall survival by RPA (Recursive Partitioning Analysis) class.
Figure 4
Figure 4
Local control by treatment modality.
Figure 5
Figure 5
Distant brain progression-free survival.
See this image and copyright information in PMC

References

    1. Godley P. A., Ataga K. I. Renal cell carcinoma. Current Opinion in Oncology. 2000;12(3):260–264. doi: 10.1097/00001622-200005000-00013. - DOI - PubMed
    1. Gupta K., Miller J. D., Li J. Z., Russell M. W., Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treatment Reviews. 2008;34(3):193–205. doi: 10.1016/j.ctrv.2007.12.001. - DOI - PubMed
    1. Janzen N. K., Kim H. L., Figlin R. A., Belldegrun A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. The Urologic Clinics of North America. 2003;30(4):843–852. doi: 10.1016/s0094-0143(03)00056-9. - DOI - PubMed
    1. Najjar Y. G., Rini B. I. Novel agents in renal carcinoma: a reality check. Therapeutic Advances in Medical Oncology. 2012;4(4):183–194. doi: 10.1177/1758834012443725. - DOI - PMC - PubMed
    1. Remon J., Lianes P., Martínez S. Brain metastases from renal cell carcinoma. Should we change the current standard? Cancer Treatment Reviews. 2012;38(4):249–257. doi: 10.1016/j.ctrv.2011.06.008. - DOI - PubMed

LinkOut - more resources